BioCentury
ARTICLE | Cover Story

2012 gets a new deal

February 7, 2013 8:00 AM UTC

SciBX's second annual comprehensive analysis of public-private partnerships and early stage venture financing activity reveals that government institutions and organizations are taking a significant role in forming and funding partnerships, and California-based companies are leading the way in public-private partnership activity. On the financing front, biotech startups in the San Francisco Bay Area took in the lion's share of early stage venture dollars despite a year-over-year decline in worldwide early stage venture investments in biotechs.

The specific business areas that public-private partnerships (PPPs) focused on in 2012 closely mirrored 2011, with cancer taking the top spot both years (see "Business areas covered by 2012 public-private partnerships"). PPPs in the infectious diseases space-the second most active area in 2011-moved down a spot to third and swapped positions with PPPs working in diagnostics and pharmacogenetics (see Figure 1.I and Figure 1.II)...